Pharmaceutical benefits scheme criteria for the use of tumour necrosis factor-alpha inhibitors in the treatment of ankylosing spondylitis in Australia: are they evidence based?

Malcolm Smith, Michael Ahern

    Research output: Contribution to journalArticle

    4 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)72-76
    Number of pages5
    JournalInternal Medicine Journal
    Volume36
    Issue number2
    Publication statusPublished - 2006

    Cite this